Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
Summary
The study of mammalian immune cells and their interactions with tissue in situ is critical for understanding
how they regulate processes ranging from wound healing to autoimmune disease initiation to cancer and for
designing better therapeutic strategies to treat these prevalent conditions. Intravital multiphoton microscopy
(MPM) combined with a rich repertoire of fluorescent reporter mouse models and in vivo cell and tissue labeling
techniques have made it possible to visualize immune cell-tissue interactions at a subcellular level in skin and
other organs. However, there are significant differences in the structure and immune milieu of human skin that
limits the translatability of these findings to the human cutaneous immune response. Our group has recently
developed a fast large area multiphoton exoscope (FLAME), a unique imaging platform optimized for efficient
clinical skin imaging to rapidly generate macroscopic images (mm to cm-scale) with microscopic resolution (0.5-
1µm) based on label-free molecular contrast (fluorescence intensity and lifetime). In this application, we leverage
our extensive experience in MPM technology development and clinical imaging of more than 400 patients over
the past several years to develop the first MPM-based clinical device (iFLAME) as a research imaging tool
optimized for, and dedicated to, in vivo label-free imaging of immune cell populations and their dynamics in
human skin. In Aim 1, we develop iFLAME as a clinical research tool for efficient in vivo label-free imaging of
dermal cell populations and their dynamics in human skin. This work involves development of detection and
analytic approaches as well as optical and computational methods to enable rapid fluorescence lifetime detection
and analysis necessary to automate measurements of the cellular morphological and metabolic signatures. In
Aim 2, we validate iFLAME performance by demonstrating in vivo characterization of immune cells in normal
and inflamed human skin. In Aim 3, we develop quantitative morphological and metabolic MPM imaging
endpoints to assess immune infiltrates and their dynamics in human skin in the context of monitoring wound
healing. This work represents the first attempt to use intrinsic sources of MPM contrast to image, identify, and
quantify key immune cells in human skin in vivo based on their optical signatures and migratory behavior. Our
long-term goal is to develop iFLAME as a clinical research tool for rapid, label-free imaging of immune cells in
skin based on cellular morphologic and metabolic imaging endpoints. These can be used to better understand,
evaluate and optimize wound healing, autoimmune skin diseases and therapeutic responses.
Public Health Relevance Statement
Narrative
In this application we develop iFLAME, a fast, large area multiphoton exoscope optimized for in vivo label-free
imaging of immune cell populations and their dynamics in human skin. We validate iFLAME performance by
demonstrating its ability to discriminate immune cells in vivo and develop quantitative morphological, metabolic
and dynamic imaging endpoints to assess immune infiltrates in human skin during the wound healing process.
Completion of these studies will establish the practical utility and value of iFLAME as a non-invasive clinical
research tool for monitoring immune responses at the cellular level in human skin.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
046705849
UEI
MJC5FCYQTPE6
Project Start Date
01-July-2018
Project End Date
31-March-2027
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$583,873
Direct Costs
$371,894
Indirect Costs
$211,979
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$583,873
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB026705-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB026705-06
Patents
No Patents information available for 5R01EB026705-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB026705-06
Clinical Studies
No Clinical Studies information available for 5R01EB026705-06
News and More
Related News Releases
No news release information available for 5R01EB026705-06
History
No Historical information available for 5R01EB026705-06
Similar Projects
No Similar Projects information available for 5R01EB026705-06